Neos Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2020 to a ratio of 2.68, this represents a new company high. This is a clear indication for improving liquidity at Neos Therapeutics Inc 's clients. Average receivable collection period, for the Neos Therapeutics Inc in Sep 30 2020 quarter, has decreased to 136 days, compared to 138 days, in the Jun 30 2020 quarter.

If we take a look into Healthcare sector 493 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. 3333.

What is Receivable Turnover Ratio?
What is Neos Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEOS Receivables Turnover Ratio	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter
Y / Y Receivable Change	-29.4 %	-13.7 %	-10.51 %	-4.45 %	41.99 %
Y / Y Revenue Change	-28.53 %	-16.05 %	-0.96 %	9.35 %	40.29 %
Receivable Turnover Ratio (TTM)	2.68	2.65	2.68	2.62	2.53
NEOS's Total Ranking	# 3333	# 3333	# 3332	# 3331	# 3228
Accounts Receivable average collection period days	136	138	136	139	144
Seq. Receivable Change	17.26 %	-16.35 %	-21.76 %	-8.01 %	43.35 %
Seq. Revenue Change	-4.55 %	-9.38 %	-13.9 %	-4.04 %	12.13 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 190
Healthcare Sector	# 494
Overall Market	# 3333

Receivable Turnover Ratio Statistics
High	Average	Low
2.68	2.14	0.63
(Sep 30 2020)		(Jun 30 2016)

NEOS Company Profile • Back to NEOS Efficiency Comparisons • Compare NEOS Receivables Turnover Ratio to its Competitors

Financial Statements
Neos Therapeutics Inc 's Accounts Receivable	$ 20 Millions	Visit NEOS's Balance sheet
Neos Therapeutics Inc 's Sales TTM	$ 57 Millions	Visit NEOS's Income Statement
Sources of NEOS's Revenues		Visit NEOS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NEOS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NEOS's Growth Rates	NEOS's Roa	NEOS's Inventory Turnover Ratio	NEOS's Dividend Comparisons
NEOS's Profitability Ratios	NEOS's Roi	NEOS's Asset Turnover Ratio	NEOS's Dividend Growth
NEOS's Valuation Ratios	NEOS's Roe	NEOS's Financial Strength Ratios	NEOS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2020	Receivable at quarter ending Sep 30 2020
Clovis Oncology inc	7.63	$ 160.530 Millions	$ 21.028 Millions
Cardiovascular Systems Inc	7.63	$ 232.599 Millions	$ 30.471 Millions
Nuwellis Inc	7.62	$ 6.764 Millions	$ 0.888 Millions
Hanger inc.	7.59	$ 1,024.701 Millions	$ 135.003 Millions
Intuitive Surgical Inc	7.59	$ 4,307.000 Millions	$ 567.550 Millions
Cue Biopharma Inc	7.58	$ 5.767 Millions	$ 0.761 Millions
Catheter Precision Inc	7.57	$ 4.578 Millions	$ 0.605 Millions
Hca Healthcare Inc	7.56	$ 50,763.000 Millions	$ 6,710.500 Millions
Universal Health Services Inc	7.54	$ 11,368.209 Millions	$ 1,506.780 Millions
Steris Plc	7.53	$ 3,022.316 Millions	$ 401.462 Millions
Intercept Pharmaceuticals inc	7.49	$ 300.922 Millions	$ 40.182 Millions
Encision Inc	7.46	$ 7.045 Millions	$ 0.944 Millions
Cytosorbents Corporation	7.46	$ 36.479 Millions	$ 4.888 Millions
Angiodynamics Inc	7.45	$ 268.331 Millions	$ 36.012 Millions
Champions Oncology Inc	7.43	$ 37.425 Millions	$ 5.036 Millions
Catalent Inc	7.43	$ 5,421.700 Millions	$ 729.675 Millions
Star Equity Holdings Inc	7.38	$ 117.694 Millions	$ 15.945 Millions
Shockwave Medical Inc	7.36	$ 59.386 Millions	$ 8.066 Millions
Wright Medical Group N v	7.35	$ 970.174 Millions	$ 131.974 Millions
Dermtech Inc	7.32	$ 6.562 Millions	$ 0.896 Millions
Atrion Corporation	7.32	$ 149.813 Millions	$ 20.472 Millions
Quest Diagnostics Inc	7.30	$ 8,361.000 Millions	$ 1,145.500 Millions
Escalon Medical Corp	7.27	$ 9.526 Millions	$ 1.311 Millions
Igc Pharma Inc	7.26	$ 1.311 Millions	$ 0.181 Millions
Vycor Medical Inc	7.26	$ 1.226 Millions	$ 0.169 Millions
Lantheus Holdings Inc	7.25	$ 334.604 Millions	$ 46.125 Millions
Prestige Consumer Healthcare Inc	7.25	$ 959.603 Millions	$ 132.388 Millions
Edwards Lifesciences Corporation	7.21	$ 4,368.700 Millions	$ 605.950 Millions
Sanuwave Health Inc	7.20	$ 3.035 Millions	$ 0.421 Millions
Gw Pharmaceuticals Plc	7.18	$ 488.059 Millions	$ 67.968 Millions

Date modified: 2026-08-29T17:32:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.